D
Denali Therapeutics Inc. DNLI
$15.15 $0.261.75%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -422.77M -427.49M -419.65M -137.25M -145.22M
Total Depreciation and Amortization 1.09M 8.55M 8.50M 8.84M 16.73M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 57.05M 44.08M 42.82M 42.91M 60.43M
Change in Net Operating Assets 16.94M 12.23M -22.53M -327.31M -289.93M
Cash from Operations -347.69M -362.64M -390.86M -412.81M -357.99M
Capital Expenditure -15.91M -13.06M -11.24M -12.30M -12.94M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -72.84M -174.86M -169.42M -98.86M 262.25M
Cash from Investing -88.76M -187.92M -180.66M -111.16M 249.31M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -32.34M -24.02M -- -- --
Issuance of Common Stock 517.12M 517.67M 514.23M 516.49M 17.82M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -480.00K -480.00K -- -- --
Cash from Financing 484.30M 493.18M 514.23M 516.49M 17.82M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 47.85M -57.38M -57.29M -7.48M -90.86M
Weiss Ratings